Medicine
Ivra 270 mg/3 mL injection
Ivra 270 mg/3 mL injection is a prescription medicine containing Melphalan for intravenous use, marketed by Apotex, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store IVRA refrigerated at 2°C to 8°C (36°F to 46°F).
Key facts
- Active ingredient (INN)
- Melphalan
- Brand
- Ivra
- Strength
- 270 mg/3 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 3 mL
- Marketing authorisation holder
- Apotex
- Manufacturer
- Apotex
- Origin register
- US FDA, United States
- Storage
- Store IVRA refrigerated at 2°C to 8°C (36°F to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01AA03 Melphalan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2025
- Identifiers
- RxCUI 2708998, 2709003DailyMed set ID c23e868a-dc62-2181-5099-76c9226602b2NDC 60505-6414Application NDA217110
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 60505-6414-1 | Apotex | 9 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Melphalan
Clinical summary
Melphalan is an alkylating drug indicated as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. It is available as injection and powder for injection for intravenous use. MedsAcross supplies Melphalan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MelphalanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EVOMELA prescribing information (Acrotech Biopharma) · U.S. National Library of Medicine, DailyMed
- Phelinun: European public assessment report (EPAR) · European Medicines Agency
Need Ivra 270 mg/3 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.